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Abstract: Combustible tobacco users appear to be at greater risk for serious complications from
COVID-19. This study examined cigar smokers’ perceived risk of COVID-19, quit intentions,
and behaviors during the current pandemic. We conducted an online study between 23 April 2020
to 7 May 2020, as part of an ongoing study examining perceptions of different health effects of
cigars. All participants used cigars in the past 30 days (n = 777). Three-quarters of the sample
(76.0%) perceived they had a higher risk of complications from COVID-19 compared to non-smokers.
The majority of participants (70.8%) intended to quit in the next six months due to COVID-19,
and almost half of the sample (46.5%) reported making a quit attempt since the start of the COVID-19
pandemic. Far more participants reported increasing their tobacco use since COVID-19 started
(40.9%) vs. decreasing their tobacco use (17.8%). Black or African American participants, participants
who reported using a quitline, and participants with higher COVID-19 risk perceptions had higher
intentions to quit using tobacco due to COVID-19, and higher odds of making a quit attempt
since COVID-19 started. More research is needed to understand how tobacco users are perceiving
COVID-19 risks and changing their tobacco use behaviors.
Keywords: COVID-19; tobacco; cigar; risk; communication; quitting; smoking cessation
1. Introduction
Cigarette, cigar, and other combustible tobacco users appear to be at greater risk for developing
serious complications from COVID-19 [1–4]. At least four systematic reviews/meta-analyses have
concluded that smoking is associated with adverse outcomes associated with COVID-19 and worse
disease progression [1–4], which aligns with research showing that smokers are at greater risk for
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contracting and experiencing severe respiratory infections [5,6]. However, some research has suggested
that there are no associations between tobacco use and severity of COVID-19 complications, or that
using tobacco use may confer protective benefits, such as smokers being at lower risk for contracting
COVID-19 [7–10]. While there appear to be substantial limitations to this latter work [11], more research
is needed on how COVID-19 is affecting tobacco users, including how they perceive COVID-19 risks
and how they are altering their intentions and behaviors in response to this new threat.
Due to the potential negative health outcomes associated with COVID-19, it is possible that many
tobacco users feel more vulnerable to its health effects and are trying to quit using tobacco—which aligns
with both previous research and theory on risk perception [12,13]. However, it is also possible that
some tobacco users are increasing their tobacco use due to stress or anxiety associated with COVID-19,
which has also been documented in previous research on stress and smoking behavior [14–17].
One study recently examined smoking behaviors due to COVID-19, reporting descriptive changes in
smoking in a small, convenience sample [18]. More research is needed examining how tobacco users
are perceiving and reacting to COVID-19.
The goals of this study were to examine cigar smokers’ perceived risk of COVID-19, quit intentions,
and behaviors during the current pandemic. In the United States (US), cigars are one of the most
commonly used tobacco products with 7.2% of adults reporting smoking cigars in the past 30 days [19].
While cigars are used less frequently than cigarettes [19], dual use of cigarettes and cigars is high.
Research shows that between 30–60% of cigar smokers also smoke cigarettes [20], and over 30%
of cigarette smokers smoke cigars [21]. Compared to cigarette smokers, cigar smokers tend to be
younger [22], include more African Americans [22], and use cigars on fewer days per month [23,24].
We also examined how other correlates were associated with COVID-19 quit intentions and
behaviors, including demographics, such as age and race, and tobacco use variables, such as other
tobacco use and nicotine dependence. We did so because research has found several factors in the
US to be associated with risk of acquiring COVID-19 and experiencing complications, including
race/ethnicity, age, and other comorbidities. Specifically, African Americans in the US are dying of
COVID-19 at greater rates than white people, and are experiencing more complications [25]. Increasing
age and other co-morbid conditions, like types 2 diabetes, also elevate the risk of complications,
including death [26,27].
2. Materials and Methods
2.1. Participants and Procedures
We recruited participants as part of an ongoing study examining perceptions of different health
effects of cigars. Specifically, this study presented different text statements about the health effects of
cigars (e.g., cigar smoking can cause lung cancer) to participants, and asked them to answer if they
were aware of this health effect and how effective it was at discouraging their cigar use. This study will
be used to develop effective warnings for little cigar and cigarillo packages. We expanded eligibility to
include all cigar users to be more representative of the cigar smoking population. Participants were
recruited and compensated through Qualtrics Services—a leader in the field of survey software,
deployment, methodology, and consumer research. Qualtrics has existing panels that can be used
for social science research [28–30], and has a survey platform for designing and analyzing online
surveys. Qualtrics recruited participants for our study, administered the survey that we created,
compensated them, and performed an initial cleaning of the data. To be eligible for study participation,
adults had to be 18 years or older, speak English, and currently use traditional large cigars, little cigars,
or cigarillos (defined as using one of those products in the past 30 days). All participants were located
in the US. Qualtrics recruited a final sample of 777 participants for our study from 23 April 2020 to
7 May 2020. Each survey took participants 12 min on average to complete. The University of North
Carolina at Chapel Hill Institutional Review Board approved the study (study number 20-0871).
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2.2. Measures
2.2.1. Outcomes
We had two primary outcomes: (1) quit intentions in the next 6 months due to COVID-19
(average of three items, adapted from reference [31]), and (2) whether or not participants made a quit
attempt since COVID-19 started (adapted from reference [32]). To assess quit intentions, we asked
participants: “How interested are you in quitting smoking in the next 6 months because of COVID-19?”;
“How much do you plan to quit smoking in the next 6 months because of COVID-19?”; and “How likely
are you to quit smoking in the next 6 months because of COVID-19?”. For each of these three items,
response options ranged from 1 (e.g., not at all interested) to 4 (e.g., very interested). To assess
quit attempts, we asked participants: “Since COVID-19 started, how many times have you stopped
smoking for 1 day or longer because you were trying to quit smoking?”. For this item, participants
could respond with any number between 0 and 30. We dichotomized responses as no quit attempts
(for responses of 0) or at least one quit attempt (responses of 1–30). We adapted the quit intentions
and quit attempts items from previously validated measures by adding “COVID-19” to the item
stems. We also examined change in tobacco use since COVID-19 started (newly developed item)
in bivariate models but not a multivariable model for reasons described below. For this measure,
we asked participants: “Since COVID-19 started infecting people in the US, would you say that your
tobacco use has . . . ” with five response options ranging from 1 (increased a lot) to 5 (decreased a lot).
2.2.2. Correlates
We examined several correlates of interest, including participant characteristics, tobacco use
variables, and other COVID-19 variables. Participant characteristics included age, gender, sexual
orientation, race, Hispanic or Latino ethnicity, education, income, and perceived physical and mental
health status [33,34]. To assess perceived physical and mental health, we asked participants: “Would you
say that in general your physical health is . . . ” and “In general, would you say your mental health is
. . . ” with response options ranging from 1 (poor) to 5 (excellent) [33,34].
Tobacco use variables included other tobacco use [35] and nicotine dependence (using items that
assess nicotine dependence for users of multiple tobacco products) [36]. To assess other tobacco use,
we asked participants: “In the past 30 days, which of the following products have you used at least
once?” [35]. Response options included: cigarettes, smokeless tobacco (e.g., chewing tobacco, snuff,
dip, or snus), e-cigarettes, and waterpipe tobacco. Participants were allowed to select more than one
response option. We included e-cigarettes in this measure since e-cigarettes are regulated as a tobacco
product in the US. To assess nicotine dependence, we asked participants five questions about potential
symptoms of dependence on tobacco products (e.g., “During the past 30 days, have you had a strong
craving to use tobacco products of any kind?”) [36]. For all five items, participants could respond “yes”
(coded as 1) or “no” (coded as 0).
Finally, the survey assessed COVID-19 variables including quitline use since COVID-19
started (newly developed item), perceived risk of complications due to COVID-19 compared to
non-smokers (newly developed item), COVID-19 risk perceptions (average of three items, adapted
from reference [37]), and frequency of social distancing efforts (newly developed item). To assess
quitline use since COVID-19 started, we asked participants: “Since COVID-19 started, have you called
the Quitline (national phone number for help to quit smoking)?” Participants could respond “yes”
(coded as 1) or “no” (coded as 0). To assess perceived risk of complications due to COVID-19 compared
to non-smokers, we asked participants: “Please think about if you were to become infected with the
coronavirus. Compared to a non-smoker, what impact do you think that your smoking has on your
risk of serious health complications, hospitalization, and death from COVID-19?”. Response options
ranged from 1 (My smoking gives me a much higher risk of complications from COVID-19) to 5
(My smoking gives me a much lower risk of complications from COVID-19). To assess COVID-19 risk
perceptions, we asked participants three items adapted from a validated scale (e.g., How likely is it
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that you will become infected with COVID-19 at some point in the future?) with four response options
ranging from 1 (e.g., very unlikely) to 4 (e.g., very likely) [37]. Finally, to assess frequency of social
distancing efforts, we asked participants: “Physical distancing, or social distancing, is the practice of
deliberately increasing the physical space between people to avoid spreading illness. How often do
you currently practice daily social distancing as a result of COVID-19?”. Response options ranged
from 1 (never) to 5 (always). All COVID-19 measures are presented in Supplementary Table S1.
2.3. Data Analysis
We conducted analyses in SAS V.9.3 (SAS Institute, 2011, Cary, NC, USA). We first examined
bivariate associations with our two outcomes (quit intentions and quit attempts) and all correlates of
interest—participant characteristics, tobacco use variables, and other COVID-19 variables. We then
examined bivariate associations among our two primary outcomes and changes in tobacco use since
COVID-19 started (i.e., increased use, decreased use, or unchanged use). Finally, we examined
associations among all correlates and our two primary outcomes in separate multivariable models.
As our first outcome—quit intentions—was continuous, we entered all participant characteristic,
tobacco use, and COVID-19 correlates in a multivariable linear regression model. As our second
outcome—quit attempts—was dichotomous, we entered all correlates in a multivariable logistic
regression model. We included all correlates in the adjusted multivariate regression models, because we
did not have any a-priori hypotheses for which correlates would be associated with our outcomes.
While we planned to examine changes in tobacco use as a third outcome in a multivariable, multinomial
regression model, we did not run this model due to small cell counts in some of the tobacco use
response options. Results from the first model include Beta coefficients (B) and standard errors (SE).
If the B is positive, the interpretation is that for every 1-unit increase in the correlate, the outcome
variable will increase by the B value. Results from the second model include adjusted odds ratios (aOR)
and 95% confidence intervals (CI). An aOR of more than 1 means that there is a higher odds of the
outcome happening with exposure to the correlate. An aOR of less than 1 means that there is a lower
odds of the outcome happening. For all analyses, we set α = 0.05 and used 2-tailed statistical tests.
3. Results
3.1. Participants
Participant characteristics and tobacco use variables are presented in Table 1. The mean age of
participants was 39.9 (SD: 13.4), and the majority of the sample was White (66.2%), non-Hispanic or
Latino (84.9%), and straight or heterosexual (87.4%). Everyone in the sample was a cigar user and
most used other tobacco products, including cigarettes (83.8%), e-cigarettes (37.7%), smokeless tobacco
(21.9%), and waterpipe tobacco (13.3%).
COVID-19 variables are presented in Table 2. Three-quarters of the sample perceived that they
had a higher risk of complications from COVID-19, compared to non-smokers (76.0%). The great
majority of respondents (70.8%) reported intentions to quit smoking in the next six months due to
COVID-19. Almost half reported making a quit attempt (46.5%), and 22.9% reported calling a quitline
due to COVID-19. Despite these positive steps, many more participants reported increasing their
tobacco use a lot or a little since COVID-19 started (40.9%), compared to those that reported decreasing
their tobacco use a lot or a little (17.8%).
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Table 1. Participant characteristics, n = 777.
Variable N (%) Mean (SD)
Age – 39.9 (13.4)
Gender
Male 389 (50.1%) –
Female 380 (48.9%) –
Transgender or other 8 (1.0%) –
Sexual orientation
Heterosexual or straight 679 (87.4%)
Gay, lesbian, bisexual, other 98 (12.6%)
Ethnicity
Not Hispanic or Latino 659 (84.9%) –
Hispanic or Latino 117 (15.1%) –
Race
White 514 (66.2%) –
Black or African American 179 (23.0%) –
American Indian or Alaska Native 19 (2.5%) –
Asian 33 (4.3%) –
Pacific Islander 2 (0.3%) –
Other 30 (3.9%) –
Education
High school degree or less 218 (28.1%) –
Some college 161 (20.7%) –
Bachelor’s or Associate’s degree 259 (33.3%) –
Graduate degree 139 (17.9%) –
Income
Below $25,000 per year 192 (24.7%) –
Between $25,000 and $49,999 per year 192 (24.7%) –
Between $50,000 and $74,999 per year 147 (18.9%) –
Between $75,000 and $100,000 per year 112 (14.4%) –
Above $100,000 per year 134 (17.3%) –
Perceived physical health a – 3.5 (1.0)
Perceived mental health a – 3.6 (1.1)
Other tobacco products used in the past 30 days b
Cigarette 651 (83.8%)
E-cigarette 293 (37.7%)
Smokeless tobacco 170 (21.9%)
Waterpipe tobacco 103 (13.3%)
Nicotine dependence c 3.2 (1.5)
a Scores range from 1–5, higher values indicate better perceived health. b Categories are not mutually exclusive.
c Scores range from 0–5, higher values indicate more nicotine dependence.
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Table 2. COVID-19 variables, n = 777.
Variable N (%) Mean (SD)
Quit intentions in next 6 months because of COVID-19 a – 2.6 (1.1)
Quit attempt since COVID-19 started
No 416 (53.5%)
Yes 361 (46.5%)
Change in tobacco use since COVID-19 started
Increased a lot or a little 318 (40.9%) –
Stayed about the same 321 (41.3%) –
Decreased a lot or a little 138 (17.8%) –
Quitline use due to COVID-19
No 599 (77.1%)
Yes 178 (22.9%)
Perceived risk of complications due to COVID-19,
compared to non-smokers
Much higher/slightly higher risk 590 (76.0%)
Same risk 130 (16.8%)
Lower or slightly lower risk 56 (7.2%)
COVID-19 risk perceptions b – 2.6 (0.9)
Frequency of social distancing efforts c 4.6 (0.8)
a Scores range from 1–4, higher values indicate more interest in quitting. When dichotomized, 70.8% of participants
expressed intention to quit using tobacco in the next 6 months. b Scores range from 1–4, higher values indicate
higher risk perceptions. c Scores range from 1–5, higher values indicate more social distancing.
3.2. Bivariate Associations
Bivariate associations among our two outcomes with changes in tobacco use are presented in
Table 3. Interestingly, reported quit intention scores (which ranged from 1–4, with higher values
indicated more interest in quitting) were higher among people who reported decreasing their tobacco
use (2.9, SD: 1.0) and people who reported increasing their tobacco use (2.9, SD: 1.0), compared to
people who reported keeping their tobacco use the same (2.2, SD: 1.0) (p < 0.001 for both comparisons).
Similarly, participants who reported decreasing their tobacco use were more likely to report making
a quit attempt (63.0%), and participants who reported increasing their tobacco use were also more
likely to report making a quit attempt (57.6%), compared to participants who reported keeping their
tobacco use the same (28.4%) (p < 0.001). Finally, participants who reported making a quit attempt
had higher quit intentions (3.2, SD: 0.8) than participants who did not report making a quit attempt
(2.1, SD: 1.0) (p < 0.001). All bivariate associations among correlates of interest and our two outcomes
(quit intentions because of COVID-19 and quit attempts since COVID-19 started) are presented in
Supplementary Tables S2 and S3.
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Table 3. Bivariate associations among changes in tobacco use since COVID-19 started, quit intentions
due to COVID-19, and whether or not participants made a quit attempt since COVID-19 started, n = 777.








% of Group Who Made a
Quit Attempt (n/row n)
p-Value c
Increased a lot or a little 2.9 (1.0) p < 0.001 57.6% (183/318) d p < 0.001
Stayed about the same 2.2 (1.0) 28.4% (91/321)
Decreased a lot or a little 2.9 (1.0) 63.0% (87/138)
Quit Attempt since
COVID-19 Started
No 2.1 (1.0) p < 0.001 –
Yes 3.2 (0.8) –
a Scores range from 1–4, higher values indicate more interest in quitting. b p-value from ANOVA or t-test. c p-value
from chi-square test. d Row percentages are provided. For instance, the first percentage can be interpreted as:
318 participants reported increasing their tobacco use a lot or a little since COVID-19 participants. Of these
318 participants, 183 made a quit attempt. So, 57.6% of participants who increased their tobacco use a lot or a little
reported making a quit attempt since COVID-19 started.
3.3. Multivariate Associations
3.3.1. Participant Characteristics
Black or African American participants had higher quit intentions due to COVID-19 (B = 0.25,
p = 0.002) and had higher odds of making a quit attempt since COVID-19 started (aOR: 1.94, 95% CI:
1.26, 2.97), compared to White participants (Table 4). Better mental health status was associated with
higher quit intentions due to COVID-19 (B = 0.10, p = 0.005).
Table 4. Multivariable associations between correlates and quit intentions due to COVID-19 and
whether or not participants made a quit attempt since COVID-19 started, n = 777.
Variable






Age B = −0.003 (0.003), p = 0.34 0.99 (0.97, 1.00)
Gender
Male REF REF
Female B = 0.06 (0.07), p = 0.37 1.14 (0.78, 1.69)
Transgender or other B = 0.34 (0.34), p = 0.32 0.63 (0.10, 3.86)
Sexual orientation
Heterosexual or straight REF REF
Gay, lesbian, bisexual, other B = 0.005 (0.10), p = 0.96 1.15 (0.67, 1.98)
Ethnicity
Not Hispanic or Latino REF REF
Hispanic or Latino B = 0.02 (0.09), p = 0.81 1.64 (0.96, 2.78)
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Table 4. Cont.
Variable








Black or African American B = 0.25 (0.08), p = 0.002 1.94 (1.26, 2.97)
American Indian or Alaska Native B = 0.22 (0.20), p = 0.27 0.63 (0.19, 2.03)
Asian B = 0.26 (0.16), p = 0.11 0.99 (0.38, 2.58)
Pacific Islander B = −0.09 (0.63), p = 0.89 NA (cell sizes too small)
Other B = 0.17 (0.18), p = 0.35 1.18 (0.47, 2.98)
Education
High school degree or less REF REF
Some college B = −0.09 (0.09), p = 0.33 0.91 (0.55, 1.51)
Bachelor’s or Associate’s degree B = 0.05 (0.09), p = 0.55 1.06 (0.66, 1.70)
Graduate degree B = 0.15 (0.12), p = 0.21 2.50 (1.24, 5.02)
Income
Below $25,000 per year REF REF
Between $25,000 and $49,999 per year B = 0.23 (0.09), p = 0.01 1.91 (1.15, 3.17)
Between $50,000 and $74,999 per year B = 0.39 (0.10), p < 0.001 2.05 (1.19, 3.55)
Between $75,000 and $100,000 per year B = 0.35 (0.11), p = 0.002 2.00 (1.06, 3.77)
Above $100,000 per year B = 0.11 (0.12), p = 0.38 1.61 (0.81, 3.22)
Perceived physical health B = 0.03 (0.04), p = 0.43 0.94 (0.75, 1.18)
Perceived mental health B= 0.10 (0.04), p = 0.005 0.95 (0.78, 1.16)
Cigarette user
No REF REF
Yes B = −0.007 (0.09), p = 0.93 0.56 (0.34, 0.94)
E-cigarette user
No REF REF
Yes B = 0.01(0.07), p = 0.89 0.98 (0.68, 1.42)
Smokeless tobacco user
No REF REF
Yes B = 0.05 (0.09), p = 0.57 2.42 (1.47, 3.98)
Waterpipe tobacco user
No REF REF
Yes B = 0.05 (0.10), p = 0.85 0.92 (0.52, 1.63)
Nicotine dependence B = −0.007 (0.02), p = 0.75 1.11 (0.98, 1.26)
Quitline use due to COVID-19
No REF REF
Yes B = 0.47 (0.09), p < 0.001 8.66 (4.89, 15.34)
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Table 4. Cont.
Variable






Perceived risk of complications due to
COVID-19 compared to non-smoker
Much higher/slightly higher risk B = 0.47 (0.09), p < 0.001 1.52 (0.92, 2.51)
Same risk REF REF
Lower or slightly lower risk B = 0.11 (0.14), p = 0.42 1.50 (0.68, 3.28)
COVID-19 risk perceptions B = 0.38 (0.04), p < 0.001 1.31 (1.04, 1.64)
Frequency of social distancing efforts B = 0.11 (0.04), p = 0.01 1.18 (0.92, 1.50)
Note: All variance inflation factor (VIF) scores were less than 2, indicating a low risk of multicollinearity. Boldface
indicates statistical significance at p < 0.05.
3.3.2. Tobacco Use Variables
Participants who smoked cigars and cigarettes had lower odds of making a quit attempt since
COVID-19 started (aOR: 0.56, 95% CI: 0.34, 0.94), compared to participants who smoked cigars and
did not smoke cigarettes. In addition, participants who smoked cigars and used smokeless tobacco
had higher odds of making a quit attempt since COVID-19 started (aOR: 2.42, 95% CI: 1.47, 3.98),
compared to participants who smoked cigars and did not use smokeless tobacco.
3.3.3. COVID-19 Variables
Participants who reported calling a quitline had higher quit intentions due to COVID-19 (B = 0.47,
p < 0.001), and had higher odds of making a quit attempt since COVID-19 started (aOR: 8.66, 95% CI:
4.89, 15.34), compared to participants who did not report calling a quitline. Participants who believed
they had a higher risk of complications due to COVID-19, compared to non-smokers had higher quit
intentions due to COVID-19 (B = 0.47, p < 0.001) than participants who believed they had the same
risk of complications. In addition, having higher risk perceptions of COVID-19 was associated with
higher quit intentions due to COVID-19 (B = 0.38, p < 0.001) and higher odds of making a quit attempt
since COVID-19 started (aOR: 1.31, 95% CI: 1.04, 1.64). Finally, greater social distancing efforts were
associated with higher quit intentions due to COVID-19 (B = 0.11, p = 0.01).
4. Discussion
The COVID-19 epidemic has negatively impacted millions of people around the globe, particularly
those with co-morbid conditions that elevate risk of complications, including death [26]. Combustible
tobacco use appears to be a major risk factor for worse outcomes if a tobacco user contracts COVID-19 [1,
2]. Results from our study suggest that most tobacco users correctly perceive themselves to be at higher
risk of COVID-19 complications, and this risk appears to relate to intentions to quit using tobacco and
attempting to quit. This relationship appears even stronger for African Americans, who are at an even
higher risk of complications and death due to COVID-19 [25]. Yet, despite this knowledge and these
intentions / behaviors, over twice as many tobacco users reported increasing rather than decreasing
their tobacco use in our study.
These results have implications for practitioners, policy-makers, and public health agencies.
For practitioners, out results suggest that their patients who use tobacco have a heightened interest in
quitting because of COVID-19. Each year around two thirds of tobacco users want to quit and make a
quit attempt [38,39]. That the majority of tobacco users in our study, most of whom used multiple
tobacco products and displayed multiple symptoms of nicotine dependence, intended to quit and made
a quit attempt is important. To translate quit attempts into successful cessation, support for tobacco
users should be made available during this time, including increased access to nicotine replacement
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therapy, virtual support with tobacco treatment counselors, and mental health assistance, particularly
since better perceived mental health was associated with increased intentions to quit in our study.
Tailoring support to sub-groups of tobacco users may also be important. For instance, tobacco users
who have increased their tobacco use in response to COVID-19 may need additional help with higher
dependency, as well as with coping strategies for stress and anxiety. Those who have decreased their
tobacco use have an even greater chance of successfully quitting with clinician support.
Tobacco users with higher COVID-19 risk perceptions appear to have higher quit intentions
and higher odds of making a quit attempt since COVID-19 started. However, not all smokers
believed that they had a higher or similar risk of COVID-19 complications, compared to non-smokers.
These findings indicate that clear and consistent messages about risks of COVID-19 to tobacco users are
needed. Importantly, these messages may need to evolve as more data on tobacco use and COVID-19
become available.
Interestingly, we found that more people reported increasing their tobacco use (41%) than
decreasing their tobacco use (18%). Only one previous study, to our knowledge, has examined
how tobacco users have changed their behaviors in response to COVID-19 and reported similar
results. In this study of 345 dual cigarette and e-cigarette users, 30.3% of participants reported
increasing their cigarette use and 29.1% reported increasing their e-cigarette use since learning of
COVID-19 [18]. Extending these findings, we found interesting relationships between changes in
tobacco use, quit intentions, and quit attempts since COVID-19 started. Specifically, quit intentions
and odds of making a quit attempt were higher in people who reported decreasing their tobacco use
and people with higher COVID-19 risk perceptions, which is in line with what is often called the
“vulnerability hypothesis”. Indeed, both theory and research support the idea that as individuals
feel more vulnerable to the health effects of smoking, they are more likely to intend to quit smoking,
make quit attempts, and successfully quit [12,13].
However, we also found that people who reported increasing their tobacco use also reported
higher quit intentions and had higher odds of making a quit attempt—in line with research on the
“stress hypothesis”. It is possible that these people want to quit, but are stressed or anxious, and are
increasing their tobacco use despite their ‘good’ intentions. To this point, we did find that better
mental health status was associated with higher intentions to quit. In addition, people may be bored or
have stockpiled tobacco products before sheltering in place orders, which could have increased their
tobacco use. Finally, it is also possible that people may want to quit but are not able to easily access
evidence-based cessation resources like pharmacotherapy or behavioral support [40].
We also found that over a fifth of participants in our sample reported calling a quitline because of
COVID-19, and that those who reported calling a quitline had higher quit intentions and attempts.
Although the majority of US smokers are aware of quitlines [41,42], they only reach 1–2% of smokers
nationally [43,44]. However, states have been able to increase quitline reach through targeted efforts.
For instance, by adding hours of operation and implementing a cigarette tax, Maine was able to reach
over 6% of smokers [45]. In addition, the national tobacco education campaign “Tips From Former
Smokers (Tips),” which tagged many of its ads with 1-800-QUIT-NOW, led to 170,000 additional quitline
calls over a three-month period [46]. It is possible that characteristics of our study sample—which was
comprised of many heavy tobacco users—meant that participants were more likely to want to quit and
use available resources to do so. It is also possible that many people answered this question favorably
because of a social desirability bias. Regardless, our study findings indicate that many tobacco users
reported wanting to quit because of COVID-19 and reported using a quitline for help. That many
participants did not quit, suggests that tobacco quitlines may need more resources and COVID-19
specific information to help smokers quit.
Finally, we identified several characteristics that were associated with COVID-19 quit intentions
and attempts. For instance, Black or African American participants had higher quit intentions and
attempts due to COVID-19. African Americans in the US are dying of COVID-19 at greater rates
than white people and experiencing higher rates of complications [25]. This may explain why we
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observed an increased desire to quit smoking among these participants. We also found that people who
smoked cigarettes (in addition to cigars) had lower odds of making a quit attempt, compared to people
who did not smoke cigarettes, and that people who used smokeless tobacco (in addition to smoking
cigars) had higher odds of making a quit attempt, compared to people who did not use smokeless
tobacco. It is possible that smokeless tobacco users had higher odds of making a quit attempt, because
they do not want to put their fingers in their mouth to use these products. It is also possible that
people are substituting some tobacco products with others. For instance, people could be switching to
using smokeless tobacco because they are not combustible. Further research, especially longitudinal
data, are needed to understand how people are changing their patterns of tobacco use in response
to COVID-19. To our knowledge, we are the first to use and modify previously available measures
to apply to COVID-19. As tobacco control researchers continue to collect data on tobacco use and
COVID-19, the items we developed—especially those related to COVID-19 specific quit intentions,
quit attempts, and perceived risk—can be used.
Limitations
There are several limitations to this study. First, all data were self-reported, which introduces
threats of social desirability bias. Second, this was a one-time cross-sectional study, which means that
we were unable to assess temporality of associations or trends over time. Future longitudinal research
is needed to understand how COVID-19 is changing participants’ smoking and quitting behaviors.
Third, all participants were recruited online and are not representative of the US population or of
tobacco users, which means that study findings may not apply to other countries or groups of tobacco
users. Fourth, since this was a cross-sectional study and there was no possibility of randomizing
participants to different exposures, we cannot make any claims of causality. We are careful throughout
this article to use language like “correlates” rather than “predictors” and “associated with” rather
than “causes.” Fifth, we created several measures in this study that have not been previously used
(e.g., changes in tobacco use since COVID-19 started) given the novelty of COVID-19 and the rapid
research needed to understand it.
5. Conclusions
Many tobacco users included in our study perceived that they were at risk higher risk of COVID-19
complications, reported intending to quit due to COVID-19, and reported making a quit attempt since
COVID-19 started, however, more tobacco users reported increasing their tobacco use due to COVID-19
than decreasing it. More research is needed to understand how tobacco users are perceiving risks of
COVID-19 and changing their tobacco use behaviors.
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